![]() |
DATE
|
SPEAKER |
SEMINAR TITLE |
| January 26, 2001 Friday, 12:00 noon |
C. Frank Bennett, Ph.D. Antisense Research Isis Pharmaceuticals, Inc. Contact: Rudy Juliano (966-4383) |
Development of Antisense Oligonucleotides as Pharmaceuticals |
| February 23, 2001 Friday, 12:00 noon |
Alan M. Gewirtz, M.D. Stem Cell Biology and Therapeutics Program University of Pennsylvania Cancer Center Contact: Rudy Juliano (966-4383) |
Rational Development of Nucleic Acid Therapeutics for Hematologic Malignancies |
| March 16, 2001 Friday, 12:00 noon |
Leaf Huang, Ph.D. Center for Pharmacogenetics University of Pittsburgh Contact: Rudy Juliano (966-4383) |
Non-Viral Gene Therapy |
February 8, 2002 |
Frank Szoka, Ph.D. School of Pharmacy University of California, San Francisco Contact: Rudy Juliano (966-4383) |
Liposomes – their rapid evolution from a model biomembrane to a targeted drug carrier |
| March 22, 2002 Friday, 12:00 p.m. |
Dr. Lloyd Mitchell, Ph.D. Intronn Inc. Contact: Rudy Juliano (966-4383) |
Gene Reprograming by SMaRT (Spliceosome Mediated RNA Trans-splicing) |
| March 29, 2002 Friday, 12:00 p.m. |
Bruce Sullenger, Ph.D. Duke University Contact: Rudy Juliano (966-4383) |
Nucleic acid aptamers |
| April 18, 2002 Thursday, 12:00 p.m. |
Nick Dean, Ph.D. Isis Pharmaceuticals, Inc. Contact: Rudy Juliano (966-4383) |
Progress in bringing antisense into the clinic |
| Jan 10, 2003 Thursday, 12:00 p.m. |
Cy Stein, M.D. Columbia University Contact: Rudy Juliano (966-4383) |
New concepts in antisense research |
| July 15, 2003 Tuesday, 12:00 noon |
Steve Wilton, Ph.D.
Center for Neuromuscular and Neurological Disorders University of Western Australia Contact: Rudy Juliano (966-4383) |
Both ends of molecular medicine: high throughput genotyping and redirection of gene expression using antisense oligonucleotides (Application to Muscular Dystrophy) |
| October 3, 2003 Friday, 12:00 noon |
Carlos F. Barbas III, Ph.D.
Kellogg II Professor of Molecular Biology Scripps Research Institute Contact: Rudy Juliano (966-4383) |
Polydactyl zinc finger transcription factors: designing and selecting regulators of endogenous genes |
| November 7, 2003 Friday, 12:00 noon |
Scott Hammond, Ph.D.
Asst. Professor of Cell and Developmental Biology UNC-CH Contact: Rudy Juliano (966-4383) |
RNAi, microRNAs, and human disease |
| December 17, 2003 Wednesday, 12:00 noon |
Arthur Kreig, M.D.
Chief Scientific Officer Coley Pharmaceutical Group Contact: Rudy Juliano (966-4383) |
Recognition of unmethylated CpG motifs in bacterial DNA by TLR9, and activation of immunity |
| April 2, 2004 Friday, 12:00 noon |
Jacek Hawiger, M.D., Ph.D.
Oswald T. Avery Distinguished Chair of Microbiology & Immunology Vanderbilt Uni Sch of Medicine Contact: Rudy Juliano (966-4383) |
Targeting of Functional Cargo Across Plasma Membrane |
| May 6, 2004 Thursday, 12:00 noon |
Piet Herdewijn, Ph.D.
Director, Laboratory of Medicinal Chemistry Faculty of Pharmaceutical Sciences Katholieke Universiteit, Leuven, Belgium Contact: Rudy Juliano (966-4383) |
Structure and properties of modified oligonucleotides |
| November 16, 2004 Tuesday, 2:00 pm |
Alexander Kabanov, Ph.D.
Parke-David Professor of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center Contact: Rudy Juliano (966-4383) |
Polymer genomics |
| November 29, 2004 Monday, 12:00 noon |
Kam Leong, Ph.D.
Department of Biomedical Engineering Johns Hopkins University School of Medicine Contact: Rudy Juliano (966-4383) |
Delivery of biologics from fibrous scaffolds |
April 18, 2005 Monday, 4:00 p.m. |
Michael Gait, Ph.D. Contact: Rudy Juliano (966-4383) |
Targeting HIV-1 RNA-protein interactions in cells with synthetic oligonucleotides and conjugates |